From rapid to delayed and remote postconditioning: The evolving concept of ischemic postconditioning in brain ischemia

Current Drug Targets

Volumn 13, Issue 2, 2012, Pages 173-187

  Zhao, Heng ^a   Ren, Chuancheng ^a,b   Chen, Xingmiao ^c,d   Shen, Jiangang ^c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebral ischemia; Focal ischemia; Neuroprotection; Postconditioning; Preconditioning; Stroke

Indexed keywords

3 NITROPROPIONIC ACID; 3,5 DIHYDROXYPHENYLGLYCINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BRADYKININ; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CYCLOHEXIMIDE; CYTOCHROME C; DESFLURANE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOFLURANE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NORADRENALIN; PROTEIN BAX; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SEVOFLURANE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TISSUE PLASMINOGEN ACTIVATOR; TOLL LIKE RECEPTOR 4; UNINDEXED DRUG; VASCULOTROPIN; VESICULAR GLUTAMATE TRANSPORTER 1;

APOPTOSIS; ARTERY OCCLUSION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; CELL PROLIFERATION; CELL SURVIVAL; COMMON CAROTID ARTERY; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; ISCHEMIC POSTCONDITIONING; NEUROPROTECTION; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; OXYGEN TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE; STROKE; TREATMENT RESPONSE;

EID: 84863129642     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012799201621     Document Type: Article

References (153)

1. Zhao H, Sapolsky RM, Steinberg GK. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006; 26: 1114-1121.
2. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-H588.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1236.
4. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248-254.
5. Schaller B, Graf R. Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol 2002; 249: 1503-1511.
6. Schaller B, Graf R, Jacobs AH. Ischaemic tolerance: a window to endogenous neuroprotection? Lancet 2003; 362: 1007-1008.
7. Schaller BJ. Influence of age on stroke and preconditioninginduced ischemic tolerance in the brain. Exp Neurol 2007; 205: 9-19.
8. Zubakov D, Hoheisel JD, Kluxen FW, et al. Late ischemic preconditioning of the myocardium alters the expression of genes involved in inflammatory response. FEBS Lett 2003; 547: 51-55.
9. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293-1299.
10. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-1272.
11. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003; 83: 1113-1151.
12. Jin LM, Liu YX, Zhou L, et al. Ischemic preconditioning attenuates morphological and biochemical changes in hepatic ischemia/ reperfusion in rats. Pathobiology 77: 136-146.
13. Chen X, Liu X, Wan X, et al. Ischemic preconditioning attenuates renal ischemia-reperfusion injury by inhibiting activation of IKKbeta and inflammatory response. Am J Nephrol 2009; 30: 287-294.
14. Dahl NA, Balfour WM. Prolonged Anoxic Survival Due to Anoxia Pre-Exposure: Brain Atp, Lactate, and Pyruvate. Am J Physiol 1964; 207: 452-456.
15. Schurr A, Reid KH, Tseng MT, West C, Rigor BM. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res 1986; 374: 244-248.
16. Kitagawa K, Matsumoto M, Kuwabara K, et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res 1991; 561: 203-211.
17. Kitagawa K, Matsumoto M, Tagaya M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990; 528: 21-24.
18. Hashiguchi A, Yano S, Morioka M, et al. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 2004; 24: 271-2739.
19. Liu J, Bartels M, Lu A, Sharp FR. Microglia/macrophages proliferate in striatum and neocortex but not in hippocampus after brief global ischemia that produces ischemic tolerance in gerbil brain. J Cereb Blood Flow Metab 2001; 21: 361-373.
20. Yano S, Morioka M, Fukunaga K, et al. Activation of Akt/protein kinase B contributes to induction of ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab 2001; 21: 351-360.
21. Dave KR, Lange-Asschenfeldt C, Raval AP, et al. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/ gamma-aminobutyric acid release and biosynthesis. J Neurosci Res 2005; 82: 665-673.
22. Kawahara N, Wang Y, Mukasa A, et al. Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats. J Cereb Blood Flow Metab 2004; 24: 212-223.
23. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 1997; 17: 175-182.
24. Atochin DN, Clark J, Demchenko IT, Moskowitz MA, Huang PL. Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke 2003; 34: 1299-1303.
25. Raval AP, Dave KR, Mochly-Rosen D, Sick TJ, Perez-Pinzon MA. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci 2003; 23: 384-391.
26. Grabb MC, Choi DW. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci 1999; 19: 1657-1662.
27. Wu X, Qian Z, Ke Y, Du F, Zhu L. Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis. J Cell Mol Med 2009; 13: 4474-4483.
28. Della-Morte D, Dave KR, DeFazio RA, et al. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009; 159: 993-1002.
29. Ferguson AL, Stone TW. Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices. Eur J Neurosci 2008; 28: 2084-2098.
30. Sasaoka N, Kawaguchi M, Kawaraguchi Y, et al. Isoflurane exerts a short-term but not a long-term preconditioning effect in neonatal rats exposed to a hypoxic-ischaemic neuronal injury. Acta Anaesthesiol Scand 2009; 53: 46-54.
31. Raval AP, Bramlett H, Perez-Pinzon MA. Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience 2006; 141: 1721-1730.
32. Meloni BP, Tilbrook PA, Boulos S, Arthur PG, Knuckey NW. Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis. J Neurosci Res 2006; 83: 584-593.
33. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88: 581-609.
34. Tejero-Taldo MI, Gursoy E, Zhao TC, Kukreja RC. Alphaadrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. J Mol Cell Cardiol 2002; 34: 185-195.
35. Hampton CR, Shimamoto A, Rothnie CL, et al. HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts. Am J Physiol Heart Circ Physiol 2003; 285: H866-874.
36. Kaneko T, Yokoyama K, Makita K. Late preconditioning with isoflurane in cultured rat cortical neurones. Br J Anaesth 2005; 95: 662-668.
37. Cadet JL, Krasnova IN. Cellular and molecular neurobiology of brain preconditioning. Mol Neurobiol 2009; 39: 50-61.
38. Tyagi P, Tayal G. Ischemic preconditioning of myocardium. Acta Pharmacol Sin 2002; 23: 865-870.
39. Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol 1999; 380: 91-99.
40. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003; 118: 99-106.
41. Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogenactivated protein kinases. Mol Pharmacol 2004; 65: 1172-1180.
42. Nakajima T, Iwabuchi S, Miyazaki H, et al. Preconditioning prevents ischemia-induced neuronal death through persistent Akt activation in the penumbra region of the rat brain. J Vet Med Sci 2004; 66: 521-527.
43. Wick A, Wick W, Waltenberger J, et al. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 2002; 22: 6401-6407.
44. Gao X, Zhang H, Steinberg G, Zhao H. The Akt pathway is involved in rapid ischemic tolerance in focal ischemia in Rats. Transl Stroke Res 2010; 1: 202-209.
45. Di-Capua N, Sperling O, Zoref-Shani E. Protein kinase C-epsilon is involved in the denosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures. J Neurochem 2003; 84: 409-412.
46. Kurkinen K, Busto R, Goldsteins G, Koistinaho J, Perez-Pinzon MA. Isoform-specific membrane translocation of protein kinase C after ischemic preconditioning. Neurochem Res 2001; 26: 1139-1144.
47. Raval AP, Dave KR, DeFazio RA, Perez-Pinzon MA. Epsilon PKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res 2007; 1184: 345-353.
48. Shen J, Ma S, Chan P, et al. Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury. J Neurochem 2006; 96: 1078-1089.
49. Jasmin JF, Malhotra S, Singh Dhallu M, et al. Caveolin-1 deficiency increases cerebral ischemic injury. Circ Res 2007; 100: 721-729.
50. Shen J, Lee W, Li Y, et al. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells. J Neurochem 2008; 107: 478-487.
51. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolaeassociated proteins. J Biol Chem 1997; 272: 6525-6533.
52. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 1997; 272: 30429-3038.
53. Garcia-Cardena G, Martasek P, Masters BS, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem 1997; 272: 25437-25440.
54. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol 1994; 4: 231-235.
55. Oka N, Yamamoto M, Schwencke C, et al. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 1997; 272: 33416-33421.
56. Das M, Das S, Das DK. Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium. J Cell Mol Med 2007; 11: 788-797.
57. Kapinya K, Penzel R, Sommer C, Kiessling M. Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Res 2000; 872: 282-293.
58. Hara T, Hamada J, Yano S, et al. CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region. J Neurochem 2003; 86: 805-814.
59. Meller R, Minami M, Cameron JA, et al. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 234-246.
60. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001; 21: 4668-4677.
61. Bergeron M, Gidday JM, Yu AY, et al. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000; 48: 285-296.
62. Bernaudin M, Nedelec AS, Divoux D, et al. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002; 22: 393-403.
63. Ryu H, Lee J, Zaman K, et al. Sp1 and Sp3 are oxidative stressinducible, antideath transcription factors in cortical neurons. J Neurosci 2003; 23: 3597-3606.
64. Ratan RR, Siddiq A, Aminova L, et al. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 2004; 35: 2687-2689.
65. Dirnagl U, Becker K, Meisel A. Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 2009; 8: 398-412.
66. Ratan RR, Siddiq A, Smirnova N, et al. Harnessing hypoxic adaptation to prevent, treat, and repair stroke. J Mol Med 2007; 85: 1331-1338.
67. Baranova O, Miranda LF, Pichiule P, et al. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007; 27: 6320-63232.
68. Perez-Pinzon MA. Neuroprotective effects of ischemic preconditioning in brain mitochondria following cerebral ischemia. J Bioenerg Biomembr 2004; 36: 323-327.
69. Zhao H. The protective effect of ischemic postconditioning against ischemic injury: from the heart to the brain. Journal of Neuroimmune Pharmacology 2007; 2: 313-318.
70. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol 2005; 289: H2-7.
71. Sewell WH, Koth DR, Huggins CE. Ventricular fibrillation in dogs after sudden return of flow to the coronary artery. Surgery 1955; 38: 1050-1053.
72. Grech ED, Ramsdale DR. Termination of reperfusion arrhythmia by coronary artery occlusion. Br Heart J 1994; 72: 94-95.
73. Na HS, Kim YI, Yoon YW, et al. Ventricular premature beatdriven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J 1996; 132: 78-83.
74. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 2006; 70: 200-211.
75. Obal D, Dettwiler S, Favoccia C, et al. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg 2005; 101: 1252-1560.
76. Kin H, Zatta AJ, Lofye MT, et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 2005; 67: 124-1233.
77. Krolikowski JG, Weihrauch D, Bienengraeber M, et al. Role of Erk1/2, p70s6K, and eNOS in isoflurane-induced cardioprotection during early reperfusion in vivo. Can J Anaesth 2006; 53: 174-182.
78. Iliodromitis EK, Georgiadis M, Cohen MV, et al. Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs. Basic Res Cardiol 2006; 101: 502-507.
79. Dosenko VE, Nagibin VS, Tumanovskaya LV, et al. Proteasome inhibitors eliminate protective effect of postconditioning in cultured neonatal cardiomyocytes. Fiziol Zh 2006; 52: 15-24.
80. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-2148.
81. Zhao H, Wang JQ, Sun G, et al. Conditions of protection by hypothermia and effects on apoptotic pathways in a model of permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 25: S474-S474 2005.
82. Zhao H, Yenari M, Cheng D, Sapolsky R, Steinberg G. Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab 2005; 25: 1119-1129.
83. Merkle S, Frantz S, Schon MP, et al. A role for caspase-1 in heart failure. Circ Res 2007; 100: 645-653.
84. Zhao H, Shimohata T, Wang JQ, et al. Akt contributes toneuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25: 9794-9806.
85. Noshita N, Sugawara T, Hayashi T, et al. Copper/zinc superoxide dismutase attenuates neuronal cell death by preventing extracellular signal-regulated kinase activation after transient focal cerebral ischemia in mice. J Neurosci 2002; 22: 7923-7930.
86. Shimohata T, Zhao H, Steinberg GK. Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke 2007; 38: 375-380.
87. Shimohata T, Zhao H, Sung JH, et al. Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab 2007; 27: 1463-1475.
88. Chen J, Nagayama T, Jin K, et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18: 4914-4928.
89. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62: 273-295.
90. Pignataro G, Meller R, Inoue K, et al. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 2008; 28: 232-241.
91. Gao X, Ren C, Zhao H. Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 2008; 86: 2505-2511.
92. Xing B, Chen H, Zhang M, et al. Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem 2008; 105(5): 1737-1745.
93. Pignataro G, Xiong Z, Simon RP. Ischemic post-conditioning: a new neuroprotective strategy. Program No. 760.3. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience, 2006.
94. Rehni AK, Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep 2007; 59: 192-198.
95. Wang JY, Shen J, Gao Q, et al. Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats. Stroke 2008; 39: 983-990.
96. Scartabelli T, Gerace E, Landucci E, Moroni F, Pellegrini-Giampietro DE. Neuroprotection by group I mGlu receptors in a rat hippocampal slice model of cerebral ischemia is associated with the PI3K-Akt signaling pathway: a novel postconditioning strategy? Neuropharmacology 2008; 55: 509-516.
97. Burda J, Danielisova V, Nemethova M, et al. Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol 2006; 26: 1141-11451.
98. Zhou C, Tu J, Zhang Q, et al. Delayed ischemic postconditioning protects hippocampal CA1 neurons by preserving mitochondrial integrity via Akt/GSK3beta signaling. Neurochem Int 2011 (in press).
99. Nagy D, Kocsis K, Fuzik J, et al. Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress. Neuropharmacology 2011; 61: 1026-1032.
100. Ren C, Gao X, Niu G, et al. Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One 2008; 3: e3851.
101. Feng R, Li S, Li F. Toll-like receptor 4 is involved in ischemic tolerance of postconditioning in hippocampus of tree shrews to thrombotic cerebral ischemia. Brain Res 2011; 1384: 118-127.
102. Leconte C, Tixier E, Freret T, et al. Delayed hypoxic postconditioning protects against cerebral ischemia in the mouse. Stroke 2009; 40: 3349-3355.
103. Lee JJ, Li L, Jung HH, Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008; 108: 1055-1062.
104. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre-and post-conditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth 2010; 104: 191-200.
105. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 2010; 1357: 142-151.
106. Lin D, Li G, Zuo Z. Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience 2011; 179: 73-9.
107. Burda J, Danielisova V, Nemethova M, et al. Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. Cell Mol Neurobiol 2006; 26: 1139-1149.
108. Danielisova V, Nemethova M, Gottlieb M, Burda J. The changes in endogenous antioxidant enzyme activity after postconditioning. Cell Mol Neurobiol 2006; 26: 1181-1191.
109. Perez-Pinzon MA. Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol 2007; 147: 291-299.
110. Raval AP, Dave KR, Perez-Pinzon MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2006; 26: 1141-1147.
111. McClanahan T, Nao B, Wolke L, et al. Brief renal occlusion and reperfusion reduces myoardial infarct size in rabbits. FASEB J 1993; 7.
112. Oxman T, Arad M, Klein R, Avazov N, Rabinowitz B. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol 1997; 273: H1707-H1712.
113. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 1997; 96: 1641-1646.
114. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol Heart Circ Physiol 2002; 283: H29-H37.
115. Gritsopoulos G, Iliodromitis EK, Zoga A, et al. Remote postconditioning is more potent than classic postconditioning in reducing the infarct size in anesthetized rabbits. Cardiovasc Drugs Ther 2009; 23: 193-198.
116. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009; 204: 334-341.
117. Kerendi F, Kin H, Halkos M, et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 2005; 100: 404-412.
118. Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Res Cardiol 2003; 98: 149-157.
119. Zhao HG, Sun XC, Xian XH, et al. The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats. Neurochem Res 2007; 32: 1919-1926.
120. Steiger HJ, Hanggi D. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir (Wien) 2007; 149: 1-10.
121. Jin RL, Li WB, Li QJ, et al. The role of extracellular signalregulated kinases in the neuroprotection of limb ischemic preconditioning. Neurosci Res 2006; 55: 65-73.
122. Zhao HG, Li WB, Li QJ, et al. Limb ischemic preconditioning attenuates apoptosis of pyramidal neurons in the CA1 hippocampus induced by cerebral ischemia-reperfusion in rats. Sheng Li Xue Bao 2004; 56: 407-412.
123. Kakimoto M, Kawaguchi M, Sakamoto T, et al. Evaluation of rapid ischemic reconditioning in a rabbit model of spinal cord ischemia. Anesthesiology 2003; 99: 1112-1117.
124. Dave KR, Saul I, Prado R, Busto R, Perez-Pinzon MA. Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxial cardiac arrest. Neurosci Lett 2006; 404: 170-175.
125. Andreka G, Vertesaljai M, Szantho G, et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 2007; 93: 749-752.
126. Ren C, Yan Z, Wei D, et al. Limb remote ischemic postconditioning protects against focal ischemia in rats. Brain Res 2009; 1288: 88-94.
127. Wang Q, Zhang X, Ding Q, et al. Limb Remote Postconditioning Alleviates Cerebral Reperfusion Injury Through Reactive Oxygen Species-Mediated Inhibition of Delta Protein Kinase C in Rats. Anesth Analg 2011.
128. Zhou Y, Fathali N, Lekic T, et al. Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke 2011; 42: 439-444.
129. Dietrich WD, Busto R, Alonso O, Globus MY, Ginsberg MD. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats. J Cereb Blood Flow Metab 1993; 13: 541-549.
130. Dumas TC, Sapolsky RM. Gene therapy against neurological insults: sparing neurons versus sparing function. Trends Neurosci 2001; 24: 695-700.
131. Gao X, Zhang H, Takahashi T, et al. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 2008; 105: 943-955.
132. Halkos ME, Kerendi F, Corvera JS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004; 78: 961-969; discussion 969.
133. Sun HY, Wang NP, Halkos M, et al. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogenactivated protein kinase signaling pathways. Apoptosis 2006; 11: 1583-1593.
134. Yang XM, Proctor JB, Cui L, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44: 1103-1110.
135. Nemethova M, Danielisova V, Gottlieb M, Kravcukova P, Burda J. Ischemic ostconditioning in the rat hippocampus: mapping of proteins involved in reversal of delayed neuronal death. Arch Ital Biol 2010; 148: 23-32.
136. Casabona G. Intracellular signal modulation: a pivotal role for protein kinase C. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 407-425.
137. Sawe N, Steinberg G, Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 2008; 86: 1659-1669.
138. Zhao H, Sapolsky RM, Steinberg GK. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006; 34: 249-270.
139. Prasad SS, Russell M, Nowakowska M. Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K-Akt pathways. J Mol Neurosci 2011; 43: 428-442.
140. Wolfrum S, Schneider K, Heidbreder M, et al. Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res 2002; 55: 583-9.
141. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000; 278: H1571-6.
142. Brzozowski T, Konturek PC, Pajdo R, et al. Importance of braingut axis in the gastroprotection induced by gastric and remote preconditioning. J Physiol Pharmacol 2004; 55: 165-177.
143. Barone FC, White RF, Spera PA, et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 1998; 29: 1937-1950; discussion 1950-1951.
144. Meldrum DR, Cleveland JC, Jr., Rowland RT, et al. Early and delayed preconditioning: differential mechanisms and additive protection. Am J Physiol 1997; 273: H725-H733.
145. Thornton J, Striplin S, Liu GS, et al. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990; 259: H1822-H1825.
146. Xing B, Chen H, Zhang M, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 2008; 39: 2362-2369.
147. Zhang W, Miao Y, Zhou S, et al. Involvement of Glutamate Transporter-1 in Neuroprotection against Global Brain Reperfusion Injury Induced by Postconditioning in Rats. Int J Mol Sci 2010; 11: 4407-4416.
148. Zhang W, Miao Y, Zhou S, et al. Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase. J Clin Neurosci 2011; 18: 685-689.
149. Yuan Y, Guo Q, Ye Z, et al. Ischemic postconditioning protects brain from1 ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway. Brain Res 2011; 1367: 85-93.
150. Robin E, Simerabet M, Hassoun SM, et al. Postconditioning in focal cerebral ischemia: role of the mitochondrial ATP-dependent potassium channel. Brain Res 2011; 1375: 137-146.
151. + exchanger contributes to neuroprotection elicited by ischemic postconditioning. J Cereb Blood Flow Metab 2011; 31: 362-370.
152. Danielisova V, Nemethova M, Gottlieb M, Burda J. The changes in endogenous antioxidant enzyme activity after postconditioning. Cell Mol Neurobiol 2006; 26: 1179-1189.
153. Danielisova V, Gottlieb M, Nemethova M, Burda J. Effects of bradykinin postconditioning on endogenous antioxidant enzyme activity after transient forebrain ischemia in rat. Neurochem Res 2008; 33: 1057-1064.